Bacterial killing by heparin-binding peptides from PRELP and thrombospondin

Research output: Contribution to journalArticlepeer-review


Antimicrobial peptides (AMP) are effector molecules of the innate immune system. A cross-functionality exists between AMPs and heparin-binding peptides. Here, we show that the peptides QPTRRPRPGTGPGRRPRPRPR-P (QPT22), derived from proline arginine-rich end leucine-rich repeat protein (PRELP) and KRFKQDGGWSHWSPWSS (KRF17) from thrombospondin exert antimicrobial activities against the Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa, as well as against the Gram-positive Bacillus subtilis. Analysis by fluorescence microscopy demonstrated that QPT22 and KRF17 bind to bacterial membranes. Particularly QPT22 was found to induce membrane leakage of liposomes. The peptides displayed no hemolytic activities, nor did they exert membrane permeabilising effects on human epithelial cells. Additional peptides derived from heparin-binding regions of laminin, vitronectin, and fibronectin exerted similar antibacterial effects. Several peptides also showed activity against Staphylococcus aureus. Thus, the data disclose a novel antimicrobial activity of heparin-binding regions of matrix glycoproteins. The findings can be utilized in the development of novel AMPs for therapeutic use. (c) 2006 Elsevier B.V./Intemational Society of Matrix Biology. All rights reserved.
Original languageEnglish
Pages (from-to)294-300
JournalMatrix Biology
Issue number5
Publication statusPublished - 2006

Subject classification (UKÄ)

  • Dermatology and Venereal Diseases

Free keywords

  • liposomes
  • bacteria
  • heparin
  • peptide
  • antimicrobial
  • membrane


Dive into the research topics of 'Bacterial killing by heparin-binding peptides from PRELP and thrombospondin'. Together they form a unique fingerprint.

Cite this